Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Mark Kowalski, Ian Mortimer, Jeffrey Jonas

Premium

Tekmira Pharmaceuticals has appointed Mark Kowalski as its chief medical officer.

Before joining Tekmira, he was chief medical officer of YM BioSciences. He joined Gilead Sciences following its acquisition of YM.


Tekmira also disclosed that its CFO Ian Mortimer will leave the company Oct. 15. He has been with Tekmira for five years.

The search for a new CFO is underway.


Sage Therapeutics has named Jeffrey Jonas as its new CEO.

Jonas previously served as executive vice president of Isis Pharmaceuticals.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.